Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06763952 · ClinicalTrials.gov registry record · NA
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
A NA study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
NCT06763952 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 4,000 participants.
The verdict
NCT06763952, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
This study aims to investigate whether a novel artificial intelligence based screening strategy (AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education or AI-BRIDGE), which allows primary care providers to screen patients for vision-threatening diabetic eye disease in the primary care clinic, improves screening and follow-up care rates across race/ethnicity groups and reduces racial/ethnic disparities in screening.
Interventions
- OTHER AI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06763952
The ClinicalTrials.gov registry entry for NCT06763952 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AI is the first listed.
NCT06763952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06763952 about?
NCT06763952 is a clinical study titled "Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes". This study aims to investigate whether a novel artificial intelligence based screening strategy (AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education or AI-BRIDGE), which allows primary care providers to screen patients for vision-threatening diabetic eye disease in the primary...
What is the current status of trial NCT06763952?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2026-08-01. Estimated completion is 2030-05.
What interventions are being tested in trial NCT06763952?
The interventions under investigation include: AI (OTHER).
Who is sponsoring clinical trial NCT06763952?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.